The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study

Abstract Background The effect of extended adjuvant aromatase inhibition in hormone-positive breast cancer after sequential tamoxifen, aromatase inhibitor treatment of 5 years was recently investigated by the DATA study. This study found no statistically significant effect of prolonged aromatase the...

Full description

Bibliographic Details
Main Authors: Tim C. de Ruijter, Kim M. Smits, Maureen J. Aarts, Irene E. G. van Hellemond, Leander Van Neste, Bart de Vries, Petronella G. M. Peer, Jürgen Veeck, Manon van Engeland, Vivianne C. G. Tjan-Heijnen
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Diagnostic and Prognostic Research
Subjects:
Breast cancer
Predictive factors
Prognostic factors
Adjuvant treatment
Hormone receptor-positive
Endocrine treatment
Online Access:http://link.springer.com/article/10.1186/s41512-019-0065-6

Internet

http://link.springer.com/article/10.1186/s41512-019-0065-6

Similar Items